Detalles de la búsqueda
1.
Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancer.
Gynecol Oncol
; 183: 25-32, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38490057
Resultados
1 -
1
de 1
1
Próxima >
>>